PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.38%
Positive revenue growth while INTC is negative. John Neff might see a notable competitive edge here.
2.44%
Positive gross profit growth while INTC is negative. John Neff would see a clear operational edge over the competitor.
1.49%
Positive EBIT growth while INTC is negative. John Neff might see a substantial edge in operational management.
4.16%
Positive operating income growth while INTC is negative. John Neff might view this as a competitive edge in operations.
0.83%
Net income growth under 50% of INTC's 34.82%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.96%
EPS growth under 50% of INTC's 34.40%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.98%
Diluted EPS growth under 50% of INTC's 34.68%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Reduced diluted shares while INTC is at 0.05%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
14.47%
Similar OCF growth to INTC's 13.19%. Walter Schloss would assume comparable operations or industry factors.
11.93%
FCF growth similar to INTC's 11.91%. Walter Schloss would attribute it to parallel capital spending and operational models.
66.03%
Similar 10Y revenue/share CAGR to INTC's 72.46%. Walter Schloss might see both firms benefiting from the same long-term demand.
37.03%
5Y revenue/share CAGR at 75-90% of INTC's 41.80%. Bill Ackman would encourage strategies to match competitor’s pace.
14.40%
3Y revenue/share CAGR 1.25-1.5x INTC's 12.80%. Bruce Berkowitz might see better product or regional expansions than the competitor.
164.44%
10Y OCF/share CAGR above 1.5x INTC's 99.43%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
86.38%
5Y OCF/share CAGR at 75-90% of INTC's 100.43%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
21.04%
3Y OCF/share CAGR at 75-90% of INTC's 26.21%. Bill Ackman would press for improvements in margin or overhead to catch up.
301.53%
Net income/share CAGR above 1.5x INTC's 151.63% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
118.16%
5Y net income/share CAGR at 75-90% of INTC's 135.46%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
30.19%
3Y net income/share CAGR above 1.5x INTC's 20.11%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
36.59%
Below 50% of INTC's 149.84%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
28.13%
Below 50% of INTC's 66.39%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
21.31%
3Y equity/share CAGR at 50-75% of INTC's 41.95%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
688.88%
10Y dividend/share CAGR above 1.5x INTC's 63.65%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
167.47%
5Y dividend/share CAGR above 1.5x INTC's 33.52%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.28%
3Y dividend/share CAGR above 1.5x INTC's 15.67%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
3.90%
AR growth is negative/stable vs. INTC's 12.60%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.38%
Inventory shrinking or stable vs. INTC's 11.13%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
12.96%
Asset growth 1.25-1.5x INTC's 8.65%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
8.95%
BV/share growth above 1.5x INTC's 5.41%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
23.80%
Debt growth far above INTC's 13.82%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-0.77%
Our R&D shrinks while INTC invests at 2.37%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.06%
We cut SG&A while INTC invests at 4.69%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.